Piper Sandler announced Gilead Sciences (NASDAQ:GILD) Price Target of $105

By / / Gilead Sciences, Piper Sandler

Piper Sandler analyst Joseph Catanzaro assumes Gilead Sciences (NASDAQ:GILD) with a Overweight rating and announces Price Target of $105.

Scroll to Top